[Consumption coagulopathies and severe postpartum hemorrhage]

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Critical Care Medicine

Context:

• Severe postpartum hemorrhage (PPH) presents a critical obstetric emergency.
• PPH can stem from retroplacental hematoma or secondary bleeding sites (placental site, cervical/vaginal tears).
• Associated clinical picture includes shock, massive bleeding, and coagulopathy unresponsive to standard blood products.

Purpose:

• To investigate the efficacy of early heparin therapy in managing severe PPH with consumption coagulopathy.
• To identify etiological factors contributing to PPH and its complications.
• To establish preventive and curative therapeutic strategies for PPH.

Summary:

• Fifteen patients with severe PPH were studied, with complications arising from retroplacental hematoma or secondary bleeding.
• Coagulation pathology due to consumption defects was evident in all cases.
• Early heparin treatment (1-3 mg/kg/24h) with strict monitoring and supportive care was successful in 9 cases.
• Delayed treatment, inadequate blood replacement, or antifibrinolytic use led to fatal outcomes (shock, C.I.V.D.).

Impact:

• Highlights the critical role of early diagnosis and intervention in PPH management.
• Demonstrates the effectiveness of heparin therapy in specific PPH-related coagulopathies.
• Emphasizes the need for comprehensive management strategies, including prevention and timely treatment, to reduce PPH mortality.